title: Ten year experience with renal transplantation in juvenile onset diabetics.
abstract: Between 1968 and 1978, 305 juvenile onset diabetic patients with uremia and 462 nondiabetic uremic patients of similar age received primary renal allografts at the University of Minnesota. Two hundred eight of the diabetic patients are alive and 190 have functioning renal grafts three months to ten years after transplantation. Cumulative patient survival rates at two years for diabetic recipients of kidneys from HLA identical siblings, other related and cadaver donors are 90, 73 and 68%, respectively, the corresponding graft functional survival rates are 90, 67 and 55%. For nondiabetic patients receiving kidneys from the same donor categories the corresponding patient survival rates are 97, 86 and 75%, while the graft functional survival rates are 94, 77 and 64%. The differences in patient and graft survival between diabetic and nondiabetic recipients are statistically significant only for the patients receiving grafts from HLA-nonidentical related donors. For all recipients under the age of 30, there are no statistically significant differences in patient and graft survival. Regardless of the age of the patient or the source of the kidney, the survival of diabetic patients treated with transplantation at our institution is better than the use of chronic hemodialysis, alone. Technical complications do not occur more frequently in diabetic transplant recipients. Cardiovascular disease is responsible for most of the late deaths in these diabetic patients. Amputations of digits or extremities have been required in 15% of the diabetic patients. On the positive side, the vision of 88% of these recipients remained stable or had improved visual acuity, and 82% of the diabetic patients were actively rehabilitated after transplantation. Kidney transplantation is the treatment of choice for end-stage renal failure in diabetic patients, just as it is for most uremic patients.
mesh_terms: D000328:Adult; D000367:Age Factors; D002102:Cadaver; D003922:Diabetes Mellitus, Type 1; D003925:Diabetic Angiopathies / Q000175:diagnosis; D003928:Diabetic Nephropathies / Q000601:surgery* / Q000628:therapy; D003930:Diabetic Retinopathy / Q000175:diagnosis; D005190:Family; D005260:Female; D006085:Graft Survival; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D009026:Mortality; D011183:Postoperative Complications; D006435:Renal Dialysis; D012737:Sex Factors; D014019:Tissue Donors; D014184:Transplantation, Homologous; D014511:Uremia / Q000601:surgery* / Q000628:therapy
chemical_list: D006680:HLA Antigens